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Abstract
Myotonic dystrophy (DM), the commonest dystrophy in adults, is an autosomal dominant
disease characterized by a variety of multisystemic features. Two main genetically distinct
forms of DM have been identified: type 1 (DM1), the classic form first described by Steinert,
and type 2 (DM2), identified by Ricker. DM1 is caused by trinucleotide expansion of cytosine-
-thymine-guanine (CTG) in the myotonic dystrophy protein kinase gene, whereas in DM2 the
expansion of tetranucleotide repeats (CCTG) in the zinc finger protein 9 gene was identified.
Both mutations are dynamic and are located in non-coding parts of the genes. Phenotype
variability of DM1 and DM2 is caused by a molecular mechanism due to mutated RNA
toxicity. DM1 is characterized by myotonia and multi-organ damage with major cardiac
involvement. The disease is usually slowly progressive and life expectancy is reduced by the
increased mortality associated with cardiopulmonary complications. Sudden death can occur
as a consequence of cardiac-conduction abnormalities. We present the ECG of a 26 year-old
male  with DM1 and progressive conduction system disturbance characterized by syncopal
episodes. (Cardiol J 2011; 18, 3: 322–325)
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Electrocardiographic description
This is a 12-lead electrocardiogram (ECG) of
a 26 year-old male patient with myotonic dystrophy
type 1 (DM1) diagnosed eight years previously,
with severe distal muscular weakness, gait, speech
and mastication disorders, and mild mental retar-
dation. A positive family history with similar mani-
festations was present (mother and brother, the
latter presenting with sudden death at the age of
34). Two years ago, our patient had a cholecystec-
tomy with prophylactic temporary pacemaker im-
plantation during surgery, due to severe conduction
system disturbances (Fig. 1A).
He was admitted to the intensive care unit due
to a syncopal episode of one minute’s duration. He
had suffered diarrhea for the previous four days. On
admittance, the patient was in no distress, with
amnesia of the syncopal episode. Heart rate was
50 bpm, blood pressure was 110/70 mm Hg and he
was afebrile. Remarkable features of his physical exa-
mination were myotonia of the tongue and extremi-
ties. Cardiovascular, respiratory and abdominal ex-
amination was unremarkable. Lab tests showed
hypomagnesemia (1.1 mg/dL, range: 1.5–2 mg/dL)
and hypocalcemia (7.1 mg/dL, range: 8.5–10.5 mg/
/dL). The baseline ECG showed sinus bradycardia
(heart rate 40 bpm), left atrial enlargement, first-
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Figure 1: Electrocardiogram description. A. Classical left bundle branch block (LBBB) pattern, supraventricular
command (sinus rhythm), normal PR interval (160 ms), QRS axis near 0° (frequent in LBBB), QRS duration of 160 ms.
QRS complex of the rS type in right precordial leads, monophasic, broad notched or slurred R wave in the left leads
(I, aVL, V5, V6), R-peak time or intrinsicoid deflection in I, V5–V6 ≥ 60 ms but normal in V1–V2 and V3, characteristic
absence of initial q waves in leads I, V5 and V6. ST-T opposite to a greater deflection of QRS: positive from V1 to V4
and negative in left leads I, aVL, V5 and V6. These are alterations secondary to ventricular repolarization with wide
QRS-ST-T angle and normal ventricular gradient; B. Incomplete right bundle branch block (IRBBB) and second
degree AV block. Conducted P waves showing PR interval prolongation (from 240 to 280 ms) suggesting 2nd degree
AV block Mobitz type II; C. Frontal plane leads I, II and III showing sinus rhythm with LBBB QRS morphology in the
first three beats. The fourth P wave is not conducted (P wave not followed by a QRS complex), aVR, aVL and aVF
shows only two normal P-QRS complexes with LBBB pattern. The fourth beat shows a P wave not followed by
correspondent QRS complex. Precordial leads show complete AV dissociation; ventricular heart rhythm 34 bpm and
atrial heart rhythm 62 bpm. QRS pattern: wide QRS complexes with left leads showing LBBB pattern and V1 triphasic
QRS broad (150 ms) pattern suggestive of IRBBB (alternating bundle branch block); D. Complete AV block with QRS
complexes showing alternating bundle branch block (LBBB and RBBB). From V4 to V6, we observe three QRS
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-degree atrioventricular (AV) block (PR interval of
280 ms), incomplete right bundle branch block, and
prolonged QTc interval (QTc = 508 ms). During the
admission, the electrolytic disturbance was correct-
ed. During the following 24 hours, the patient expe-
rienced a fresh syncopal episode while at rest. The
ECG showed heart rate of 35 bpm with complete AV
block, alternating bundle branch block pattern (right
and left bundle branch block; Figs. 1C, D). A perma-
nent pacemaker was implanted.
Points to ponder
DM1, first described by Steinert, is the most
frequently inherited adult neuromuscular disease,
accounting for 98% of all myotonic dystrophy cas-
es. This is a multi-system disease with major car-
diac involvement. Core features are myotonia (de-
layed muscle relaxation after contraction), progres-
sive weakness and atrophy of the skeletal muscles,
cataract, and systemic manifestations, including car-
diac involvement [1, 2]. Classical DM1 has been
identified as an autosomal dominant disorder asso-
ciated with the presence of an abnormal expansion
of a cytosine-thymine-guanine (CTG trinucleotide)
repeat on chromosome 19q13.3 (the DM1 locus).
Its incidence is estimated to be one in every 8,000
births annually and its prevalence is estimated at
1/20,000 inhabitants [3–5].
Endomyocardial biopsies and post mortem
studies performed on patients with DM1 have do-
cumented various degrees of non-specific changes,
such as interstitial fibrosis, fatty infiltration, hyper-
trophy of cardiomyocytes, and focal myocarditis.
A selective and extensive impairment of the con-
duction system is the commonest finding [6]. Res-
piratory failure and cardiovascular disease are the
most prevalent causes of death, accounting for about
40% and 30% of fatalities, respectively [7, 8].
The hypothesis that cardiac arrhythmias may
be the most prevalent cause of sudden death in DM1
patients is supported by the absence of other caus-
es of sudden death found at autopsies [6].
Sudden cardiac death may be caused by cardiac
arrest, ventricular tachycardia (VT) with degene-
ration in ventricular fibrillation (VF) or progression
to complete AV block [9, 10]. Conduction system
abnormalities are commonly observed in DM1. Any
part of the conduction system can be affected, but
the intraventricular His-Purkinje system is the
most frequently involved. Minor conduction defects
are often present in the ECGs of asymptomatic pa-
tients in the early stages of disease. Their progres-
sion towards more severe conduction defects may
cause shortness of breath, dizziness, fainting, syn-
cope, and sudden death. The rate of progression of
the conduction abnormalities is usually slow, but
occasionally quick, thus making the clinical course
of individual patients unpredictable [7]. Delayed
impulse propagation along the conduction system
can be associated with a long PR interval and/or with
a wide QRS complex. Delayed myocardial activation
in DM1 is not a consequence of inhomogeneous
conduction through scattered areas of fibrosis, but
rather of delayed activation along the intraventri-
cular His-Purkinje system [7, 9, 11].
Groh et al. [12], in 406 adult patients with ge-
netically confirmed DM1, showed severe abnormali-
ties on the ECG: no sinus rhythm, PR interval and
QRS duration prolongation (≥ 240 ms and ≥ 120 ms,
respectively), or second or third-degree AV block.
A diagnosis of atrial tachyarrhythmia was an inde-
pendent risk factor for sudden death. During the
follow-up, 20% of the patients died, with one in
three of the deaths being sudden.
A careful cardiac evaluation including basal
ECG, 24 hour Holter monitoring and echocardiogram
should be routinely performed in all patients present-
ing with DM1. A history of fainting, palpitation, short-
ness of breath, presyncope or syncope should be
carefully researched by interviewing not only the
patient but also his or her relatives. Asymptomatic
AV conduction delay, in particular in the presence
of a prolonged HV interval, represents one of the
major therapeutic challenges in DM1, as data on the
rate of progression to complete AV block is contra-
dictory. On the basis of nonrandomized observations,
some investigators have recommended pacemaker
implantation for patients with DM1 and asympto-
matic cardiac conduction abnormalities [9, 13].
Conclusions
Patients with DM1 are at high risk of severe
cardiovascular events, including sudden death. ECG
abnormalities could potentially help predict them.
Prophylactic pacemaker implantation in DM1 pa-
tients who are identified as being at risk of sudden
death according to Groh’s criteria [12] reduces the
incidence of sudden death. However, pacemaker
implantation cannot entirely forestall this event
once VTs/VF are involved in the sudden deaths of
DM1 patients. In such cases, an implantable cardiac
defibrillator could be indicated.
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